The country has also declined in regions with high malaria prevalence from 11 in 2017 to seven in 2020 thanks to the Tanzania Biotech Products Limited (TBPL) which has proved to an efficient national biological arsenal aimed at eliminating malaria through the production of biolarvicide.
Minister of Health, Community Development, Gender, Elderly and Children Dr Dorothy Gwajima said in a written response to a question by opposition Special Seats legislator Halima Mdee.
The MP wanted to know the contribution of the factory in fight against malaria in the country.
The minister said in response that since TBPL—the subsidiary company of National Development Corporation (NDC)—started production in 2016 a total of 340,520 litres of biolarvicide have been bought by the government from the factory at a cost of 4.5bn/- which is an average of 13,200/- per litre.
The chemicals have been distributed to 28 regions and 185 district and municipal councils across the country.
“The efforts includes implementation of other ways of controlling the spread of the disease such the use of treated nets ,” she said.
The minister assured the MP and the country at large that the government will continue to use products from the factory to achieve the goal of eliminating malaria whereby the country intends to reduce malaria prevalence to 3.5per cent by 2025 from 7.5per cent in 2017.
She further said every district council is entitled and accountable to ensure it set aside funds for purchasing the chemicals every financial year.
MALARIA prevalence in the country decreased by half from 14.4 per cent recorded in 2016 to 7.3 in 2018, a study by National Bureau of Statistics (NBS) showed.
According to the 2017 Tanzania malaria indicator survey the rate reached 7.3 per cent in 2017 from 14.4 per cent in 2015.